Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $2.9484 per EA under NDC 82009008730. Its NADAC has been published 135 times since Nov 29, 2023.
Strength
400 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009008730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212773On Market Since
9/1/2023
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 135 times since Nov 29, 2023, and over the history we have for it it has risen 65.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.9484 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $1.5602 (Jan 17, 2024) |
| 52-week high | $3.2150 |
| 52-week low | $2.6631 |
| Median price | $2.6065 |
| Average price | $2.5130 |
| Largest weekly change | +27.4% (Jun 19, 2024) |
| Weeks tracked | 135 |
| Tracking since | Nov 29, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $2.9484 per EA (NDC 82009008730), effective Jun 24, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 65.7%. It has been tracked across 135 weekly CMS publications since Nov 29, 2023.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Nov 29, 2023, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.5602 (Jan 17, 2024) to a high of $3.2150 (Mar 11, 2026), with a median of $2.6065 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
5 NADAC-published products share the same active ingredient, strength, and dosage form as IMATINIB MESYLATE 400 MG TAB, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 82009008730) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification